International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064


Downloads: 0 | Views: 104

Case Studies | Pathology | India | Volume 11 Issue 11, November 2022


Role of Fine Needle Aspiration Cytology in Diagnosis of Salivary Gland Lesions

Dr. Mona Patel [3] | Dr. Chetan Dharaiya | Dr. Jignasa Bhalodia


Abstract: Background: FNAC of salivary gland lesions is the best technique for the diagnosis of salivary gland lesions. Salivary gland lesions represent clinical and morphological diversity, which is a difficult task for histopathological interpretation. Aims and objectives: To evaluate the spectrum of salivary gland lesions and to assess the diagnostic accuracy of FNAC for salivary gland lesions. Material and methods: Patients were referred to the Department of Pathology, GMERS Medical College Sola, Ahmedabad for period of 3 years, for palpable salivary gland swelling on whom FNAC procedure was performed were included in the study. Results: In our study, total 72 patients underwent FNAC during the period of 3 years. Out of 72 cases, 37cases were non-neoplastic and 35 cases were neoplastic. Among 35 cases, 27 cases were benign and 8 cases were malignant. Male to female ratio was 1.7: 1. Majority of cases were seen in the 5th decade of life. Among allsalivary lesions, commonest lesion was pleomorphic adenoma. Mucoepidermoid carcinoma was most common among all malignant salivary gland lesions. Conclusions: FNAC has significant diagnostic value in differentiating neoplastic from non-neoplastic lesions and offers valuable information for planning and subsequent disease management.


Keywords: Fine needle aspiration cytology, salivary gland, pleomorphic adenoma, mucoepidermoid carcinoma


Edition: Volume 11 Issue 11, November 2022,


Pages: 586 - 590


How to Download this Article?

Type Your Valid Email Address below to Receive the Article PDF Link


Verification Code will appear in 2 Seconds ... Wait

Top